Seattle, WA, United States of America

Cameron Brandt

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 7.3

ph-index = 4

Forward Citations = 81(Granted Patents)


Company Filing History:


Years Active: 2006-2024

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Cameron Brandt

Introduction

Cameron Brandt is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of biotechnology. With a total of 12 patents to his name, Brandt has focused on developing innovative solutions for medical challenges, particularly in the realm of cancer treatment and human papillomavirus (HPV) research.

Latest Patents

Among his latest patents, Brandt has developed HPV-specific binding molecules. These include binding molecules such as T cell receptors (TCRs) and antibodies that specifically recognize or bind to human papillomavirus (HPV) 16, including its E6 and E7 proteins. His work also encompasses engineered cells that contain these binding molecules, as well as compositions and methods for treatment involving the administration of these innovative solutions. Another notable patent involves T cell receptors and engineered cells expressing these receptors, which target peptide epitopes of cancer antigens expressed on cancer cells, including those infected with HPV. This research has significant implications for adoptive cell therapy, showcasing Brandt's commitment to advancing cancer treatment.

Career Highlights

Cameron Brandt has had a distinguished career, working with notable companies such as Zymogenetics, Inc. and Juno Therapeutics GmbH. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research and development.

Collaborations

Throughout his career, Brandt has worked alongside talented individuals, including Wenfeng Xu and Brian A. Fox. These collaborations have further enriched his research and innovation efforts, leading to advancements in therapeutic technologies.

Conclusion

Cameron Brandt's innovative work in biotechnology, particularly in the development of binding molecules and engineered cells for cancer treatment, highlights his role as a leading inventor in the field. His contributions continue to pave the way for new therapeutic approaches, demonstrating the impact of his research on public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…